Daiken Biomedical Co., Ltd.
Daiken Biomedical Co., Ltd. engages in the research and development of healthy food products. The company is based in Taipei, Taiwan. Daiken Biomedical Co., Ltd. is a subsidiary of Sunfun Info Co., Ltd.
Market Cap & Net Worth: Daiken Biomedical Co., Ltd. (7780)
Daiken Biomedical Co., Ltd. (TW:7780) has a market capitalization of $472.51 Million (NT$15.63 Billion) as of March 18, 2026. Listed on the TW stock exchange, this Taiwan-based company holds position #16963 globally and #680 in its home market, demonstrating a -12.87% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Daiken Biomedical Co., Ltd.'s stock price NT$19.30 by its total outstanding shares 810024170 (810.02 Million).
Daiken Biomedical Co., Ltd. Market Cap History: 2025 to 2026
Daiken Biomedical Co., Ltd.'s market capitalization history from 2025 to 2026. Data shows growth from $4.39 Billion to $472.51 Million (0.00% CAGR).
Daiken Biomedical Co., Ltd. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Daiken Biomedical Co., Ltd.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of 7780 by Market Capitalization
Companies near Daiken Biomedical Co., Ltd. in the global market cap rankings as of March 18, 2026.
Key companies related to Daiken Biomedical Co., Ltd. by market ranking:
- Nestle SA (PINK:NSRGF): Ranked #55 globally with a market cap of $258.19 Billion USD.
- Nestlé S.A. (SW:NESN): Ranked #68 globally with a market cap of $226.90 Billion USD ( CHF207.77 Billion CHF).
- Danone S.A (OTCQX:GPDNF): Ranked #437 globally with a market cap of $49.73 Billion USD.
- Danone SA (PA:BN): Ranked #458 globally with a market cap of $47.46 Billion USD ( €46.23 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #55 | Nestle SA | PINK:NSRGF | $258.19 Billion | $100.43 |
| #68 | Nestlé S.A. | SW:NESN | $226.90 Billion | CHF80.84 |
| #437 | Danone S.A | OTCQX:GPDNF | $49.73 Billion | $78.67 |
| #458 | Danone SA | PA:BN | $47.46 Billion | €73.12 |
Daiken Biomedical Co., Ltd. Historical Marketcap From 2025 to 2026
Between 2025 and today, Daiken Biomedical Co., Ltd.'s market cap moved from $4.39 Billion to $ 472.51 Million, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | NT$472.51 Million | -89.25% |
| 2025 | NT$4.39 Billion | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Daiken Biomedical Co., Ltd. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $472.51 Million USD |
| MoneyControl | $472.51 Million USD |
| MarketWatch | $472.51 Million USD |
| marketcap.company | $472.51 Million USD |
| Reuters | $472.51 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.